0000947871-19-000520.txt : 20190716 0000947871-19-000520.hdr.sgml : 20190716 20190716095200 ACCESSION NUMBER: 0000947871-19-000520 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20190716 DATE AS OF CHANGE: 20190716 EFFECTIVENESS DATE: 20190716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OrbiMed Partners, Ltd. CENTRAL INDEX KEY: 0001459984 IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-129096 FILM NUMBER: 19956334 BUSINESS ADDRESS: STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR CITY: New York STATE: NY ZIP: 10022 BUSINESS PHONE: 212-739-6400 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR CITY: New York STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Caduceus Capital, Ltd. DATE OF NAME CHANGE: 20110310 FORMER COMPANY: FORMER CONFORMED NAME: Caduceus Capital Ltd. DATE OF NAME CHANGE: 20100311 FORMER COMPANY: FORMER CONFORMED NAME: Caduceus Capital LTD DATE OF NAME CHANGE: 20090326 D/A 1 primary_doc.xml X0708 D/A LIVE 0001459984 OrbiMed Partners, Ltd. C/O ORBIMED CAPITAL LLC 601 LEXINGTON AVE, 54TH FLOOR NEW YORK NY NEW YORK 10022 212-739-6400 VIRGIN ISLANDS, BRITISH None Caduceus Capital, Ltd. Caduceus Capital Ltd. Caduceus Capital LTD Other Business Company true - OrbiMed Capital LLC 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY NEW YORK 10022 Promoter Investment Advisor Sven H. Borho 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY NEW YORK 10022 Director Graham B.R. Collis CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 BERMUDA HM 11 Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000947871-10-000265 1996-12-01 true true true false 100000 Far Hills Group, LLC 32243 None None 747 3RD AVENUE 30TH FLOOR NEW YORK NY NEW YORK 10017 All States false J.P. Morgan Securities LLC 79 None None 383 MADISON AVENUE NEW YORK NY NEW YORK 10179 All States false Indefinite 2511256097 Indefinite true 2 759 34120891 true 0 Subject to future contingencies. 0 The fund charges a management fee that is described in the fund's offering documents. false OrbiMed Partners, Ltd. /s/ Sven H. Borho Sven H. Borho Director 2019-07-16